163 related articles for article (PubMed ID: 34671118)
1. E. faecalis promotes liver carcinogenesis.
Ray K
Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):832-833. PubMed ID: 34671118
[No Abstract] [Full Text] [Related]
2. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
[TBL] [Abstract][Full Text] [Related]
3. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
4. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
Schwabe RF; Greten TF
J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
[TBL] [Abstract][Full Text] [Related]
6. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
7. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
[TBL] [Abstract][Full Text] [Related]
8. What's new in NAFLD pathogenesis, biomarkers and treatment?
Byrne CD; Targher G
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):70-71. PubMed ID: 31740806
[No Abstract] [Full Text] [Related]
9. The gut microbiome and liver cancer: mechanisms and clinical translation.
Yu LX; Schwabe RF
Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Boursier J; Diehl AM
Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
[TBL] [Abstract][Full Text] [Related]
12. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
Ezzaidi N; Zhang X; Coker OO; Yu J
Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249
[TBL] [Abstract][Full Text] [Related]
13. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.
Reuter B; Bajaj JS
Clin Liver Dis; 2020 Aug; 24(3):493-520. PubMed ID: 32620285
[TBL] [Abstract][Full Text] [Related]
14. The unforeseen intracellular lifestyle of
Nunez N; Derré-Bobillot A; Trainel N; Lakisic G; Lecomte A; Mercier-Nomé F; Cassard AM; Bierne H; Serror P; Archambaud C
Gut Microbes; 2022; 14(1):2058851. PubMed ID: 35373699
[No Abstract] [Full Text] [Related]
15. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma.
Thilakarathna WPDW; Rupasinghe HPV; Ridgway ND
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807605
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
17. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis.
Iida N; Mizukoshi E; Yamashita T; Yutani M; Seishima J; Wang Z; Arai K; Okada H; Yamashita T; Sakai Y; Masuo Y; Agustina R; Kato Y; Fujinaga Y; Oshima M; Honda M; Lebreton F; Gilmore MS; Kaneko S
Nat Cancer; 2021 Oct; 2(10):1039-1054. PubMed ID: 35121877
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinogenesis and Helicobacter hepaticus infection].
Shimizu N; Kaminishi M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():829-33. PubMed ID: 11762065
[No Abstract] [Full Text] [Related]
19. Microbiota, NASH, HCC and the potential role of probiotics.
Brandi G; De Lorenzo S; Candela M; Pantaleo MA; Bellentani S; Tovoli F; Saccoccio G; Biasco G
Carcinogenesis; 2017 Mar; 38(3):231-240. PubMed ID: 28426878
[TBL] [Abstract][Full Text] [Related]
20. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
